Challenge Company B, a $100MM foreign medical diagnostic company initiated IPO on domestic Form S-1, converting accounting basis from UK GAAP to US GAAP and reporting currency from Pounds Sterling to the US Dollar.
Challenge Company A, a biotech with a Phase II clinical trial asset, engaged CFGI to provide assistance with audit preparation and preparation of Form S-1 in connection with their initial public offering.
This paper explores the current regulatory environment, market trends, the preparation necessary to ensure readiness, as well as the transition and long-term effects of becoming a public company.
Despite the recent market volatility, the 2015 equity market continues to support initial public offerings (“IPOs”).
